The risk of kidney stones following bariatric surgery: A systematic review and meta-analysis

Renal Failure

Volumn 38, Issue 3, 2016, Pages 424-430

  Thongprayoon, Charat ^a   Cheungpasitporn, Wisit ^a   Vijayvargiya, Priya ^a   Anthanont, Pimjai ^a,b   Erickson, Stephen B ^a  

^a MAYO CLINIC   (United States)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

Bariatric surgery; gastric bypass surgery; kidney stones; nephrolithiasis; obesity

Indexed keywords

BARIATRIC SURGERY; COCHRANE LIBRARY; COHORT ANALYSIS; EMBASE; GASTRIC BANDING; HUMAN; MEDLINE; NEPHROLITHIASIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; ADVERSE EFFECTS; GASTRIC BYPASS SURGERY; KIDNEY CALCULI; LAPAROSCOPY; META ANALYSIS; OBESITY, MORBID; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; PROCEDURES; WEIGHT REDUCTION;

GASTRIC BYPASS; HUMANS; KIDNEY CALCULI; LAPAROSCOPY; OBESITY, MORBID; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WEIGHT LOSS;

EID: 84959245911     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2015.1137186     Document Type: Review

References (31)

1. Goldfarb DS. Increasing prevalence of kidney stones in the United States. Kidney Int. 2003; 63: 1951-1952.
2. Lieske JC, Pena de la Vega LS, Slezak JM, et al. Renal stone epidemiology in Rochester, Minnesota: An update. Kidney Int. 2006; 69: 760-764.
3. Sakhaee K. Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens. 2008; 17: 304-309.
4. Rule AD, Lieske JC, Li X, et al. The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol. 2014; 25: 2878-2886.
5. Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003; 63: 1817-1823.
6. Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005; 68: 1230-1235.
7. Ogden CL, Carroll MD, Kit BK, et al. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014; 311: 806-814.
8. Arterburn DE, Olsen MK, Smith VA, et al. Association between bariatric surgery and long-term survival. JAMA. 2015; 313: 62-70.
9. Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015; 25 (10): 1822-1321.
10. Clayman RV, Buchwald H, Varco RL, et al. Urolithiasis in patients with a jejunoileal bypass. Surg Gynecol Obstet. 1978; 147: 225-230.
11. Dhar NB, Grundfest S, Jones JS, et al. Jejunoileal bypass reversal: Effect on renal function, metabolic parameters and stone formation. J Urol. 2005; 174: 1844-1846; discussion 1846.
12. Singh D, Laya AS, Clarkston WK, et al. Jejunoileal bypass: A surgery of the past and a review of its complications. World J Gastroenterol. 2009; 15: 2277-2279.
13. Gonzalez RD, Canales BK. Kidney stone risk following modern bariatric surgery. Curr Urol Rep. 2014; 15: 401
14. Matlaga BR, Shore AD, Magnuson T, et al. Effect of gastric bypass surgery on kidney stone disease. J Urol. 2009; 181: 2573-2577.
15. Lieske JC, Mehta RA, Milliner DS, et al. Kidney stones are common after bariatric surgery. Kidney Int. 2015; 87: 839-845.
16. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med. 2014; 370: 2002-2013.
17. Semins MJ, Matlaga BR, Shore AD, et al. The effect of gastric banding on kidney stone disease. Urology. 2009; 74: 746-749.
18. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials. 1996; 17: 1-12.
19. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25: 603-605.
20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7: 177-188.
21. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003; 327: 557-560.
22. Easterbrook PJ, Berlin JA, Gopalan R, et al. Publication bias in clinical research. Lancet. 1991; 337: 867-872.
23. Asplin JR. Obesity and urolithiasis. Adv Chronic Kidney Dis. 2009; 16: 11-20.
24. Powell CR, Stoller ML, Schwartz BF, et al. Impact of body weight on urinary electrolytes in urinary stone formers. Urology. 2000; 55: 825-830.
25. Currie A, Chetwood A, Ahmed AR. Bariatric surgery and renal function. Obes Surg. 2011; 21: 528-539.
26. Fruhbeck G. Bariatric and metabolic surgery: A shift in eligibility and success criteria. Nat Rev Endocrinol. 2015; 11: 465-477.
27. Lieske JC, Kumar R, Collazo-Clavell ML. Nephrolithiasis after bariatric surgery for obesity. Semin Nephrol. 2008; 28: 163-173.
28. Semins MJ, Asplin JR, Steele K, et al. The effect of restrictive bariatric surgery on urinary stone risk factors. Urology. 2010; 76: 826-829.
29. Sinha MK, Collazo-Clavell ML, Rule A, et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int. 2007; 72: 100-107.
30. Cheungpasitporn W, Rossetti S, Friend K, et al. Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis. J Nephrol. 2015; [Epub ahead of print].
31. Cheungpasitporn W, Erickson SB, Rule AD, et al. Short term tolvaptan increases water intake and effectively decreases urinary calcium oxalate, calcium phosphate, and uric acid supersaturations. J Urol. 2015; [Epub ahead of print].